相关实验视频

Updated: May 21, 2025

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

我们如何治疗转移性阴膜黑色素瘤患者

E F Saldanha¹, M F Ribeiro¹, I Hirsch¹

¹Department of Medicine, University of Toronto, Toronto, Canada; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

|March 20, 2025

概括

泰班塔弗斯普是第一个系统性疗法,可以改善HLA-A02:01.01.HLA-A02:01.01的皮膜黑色素瘤患者的存活率. 然而,受限的资格和获取要求对这种侵袭性眼癌进行替代治疗和临床试验.

科学领域:

眼科医生眼科眼科
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

卵膜黑色素瘤是一种侵略性的眼内恶性瘤,具有与皮肤黑色素瘤不同的特征.
目前的全身疗法,包括检查点抑制剂,对于皮膜黑色素瘤提供有限的益处.
在此之前,没有一种全身疗法可以证明这种患者群体的生存结果有所改善.

研究的目的:

审查目前对转移性阴膜黑色素瘤的治疗选择.
讨论在治疗阴道黑色素瘤方面具有挑战性的情景.
为了提供正在进行的阴道黑色素瘤临床试验的概述.

主要方法:

在一个大型的第三级推中心对临床经验的审查.
提供可用的全身疗法的全面概述.
讨论治疗挑战和未来研究方向.

主要成果:

泰班塔弗斯普是第一个FDA/EMA批准的全身疗法,可改善HLA-A02:01阳性阴道黑色素瘤患者的存活率.
只有45-50%的阴道黑色素瘤患者表达HLA-A02:01,限制了tebentafusp的资格.
全球对tebentafusp的获取受到限制,缺乏临床指南.

结论:

Tebentafusp代表着一个重要的进步,但在资格和访问方面存在局限性.
转移性皮膜黑色素瘤的治疗需要考虑替代治疗方法和临床试验.
进一步的研究和指导方针的制定对于最佳的患者护理至关重要.

关键词:

这就是ImmTAC的意义.眼睛的癌症眼睛的癌症罕见的癌症罕见的癌症这样,你就有了TEBENTAFUSP.阴膜性黑色素瘤是什么

更多相关视频

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development

Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development

Published on: September 4, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.